Chesney, Jason A.; Ribas, Antoni; Long, Georgina V.; Kirkwood, John M.; Dummer, Reinhard; Puzanov, Igor; Hoeller, Christoph; Gajewski, Thomas F.; Gutzmer, Ralf; Rutkowski, Piotr; Demidov, Lev; Arenberger, Petr; Shin, Sang Joon; Ferrucci, Pier Francesco; Haydon, Andrew; Hyngstrom, John; Van Thienen, Johannes V.; Haferkamp, Sebastian; Guilera, Josep Malvehy; Rapoport, Bernardo Leon; VanderWalde, Ari; Diede, Scott J.; Anderson, James R.; Treichel, Sheryl; Chan, Edward L.; Bhatta, Sumita; Gansert, Jennifer; Hodi, Frank Stephen; Gogas, Helen
(American Society of Clinical Oncology, 2023-01)
PURPOSE : The combination of talimogene laherparepvec (T-VEC) and pembrolizumab previously demonstrated
an acceptable safety profile and an encouraging complete response rate (CRR) in patients with advanced
melanoma in ...